C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2004
10/28/2004	WO2004041151A3 Neuroprotective iron chelators and pharmaceutical compositions comprising them
10/28/2004	WO2004037205A3 LOW DOSE METHODS FOR TREATING DISORDERS IN WHICH TNFα ACTIVITY IS DETRIMENTAL
10/28/2004	WO2004029274A3 Method for generating an immune response and reagents therefor
10/28/2004	WO2004029197A3 Co-stimulatory molecules
10/28/2004	WO2004024936A3 Mutant forms of glutamate receptors mglur2 and mglur3
10/28/2004	WO2004024075A3 Chemokine receptor antagonists as therapeutic agents
10/28/2004	WO2004018709A3 Single nucleotide polymorphisms predicting adverse drug reactions and drug efficacy in cardiovascular disease
10/28/2004	WO2004018638A8 Iron transport and metabolism proteins
10/28/2004	WO2004016148A3 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors
10/28/2004	WO2004012817A3 Use of genes identified to be involved in tumor development for the development of anti-cancer drugs
10/28/2004	WO2004003176A3 Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs
10/28/2004	WO2004003157A3 Gene regulation in transgenic animals using a transposon-based vector
10/28/2004	WO2004001009A3 Apo-2 ligand/trail variants and uses thereof
10/28/2004	WO2003104415A3 Method to screen ligands using eukaryotic cell display
10/28/2004	WO2003104262A3 Gp41 peptides and methods based-thereon for inhibiting hiv fusion to target cells
10/28/2004	WO2003100020A3 Methods and constructs for high yield expression of clostripain
10/28/2004	WO2003099991A3 Glp-1 gene delivery for the treatment of type 2 diabetes
10/28/2004	WO2003095613A3 Nucleic acids, polypeptides, and methods for modulating apoptosis
10/28/2004	WO2003089573A3 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
10/28/2004	WO2003087126A3 Heteroclitic analogs and related methods
10/28/2004	WO2003074007A3 Modulators of leukocyte activation, compositions, and methods of use
10/28/2004	WO2003072738A3 Beta chain-associated regulator of apoptosis
10/28/2004	WO2003066825A3 Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy
10/28/2004	WO2003057827A3 Insulin-responsive dna binding protein-1 and methods to regulate insulin-responsive genes
10/28/2004	WO2003052064A3 Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media
10/28/2004	WO2003042661A3 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
10/28/2004	WO2003040312A3 Multifunctional green fluorescent protein and uses thereof
10/28/2004	WO2003022882A3 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
10/28/2004	WO2003020954A3 205p1b5 in treatment and detection of cancer
10/28/2004	WO2002088322A3 Cell adhesion and extracellular matrix proteins
10/28/2004	WO2001098460A3 Fusion proteins of mycobacterium tuberculosis
10/28/2004	WO2001081540A3 Growth factor which acts through erb b-4 rtk
10/28/2004	US20040216190 Expression vector for transfer and generation of freeze, herbicide, drought, heat and disease resistant plants; tissue engineering
10/28/2004	US20040216187 Preparation of deallergenized proteins and permuteins
10/28/2004	US20040216186 AXMI-006, a delta-endotoxin gene and methods for its use
10/28/2004	US20040216183 Signal transduction stress-related proteins and methods of use in plants
10/28/2004	US20040216182 Generation of plants with improved pathogen resistance and drought tolerance
10/28/2004	US20040216180 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same
10/28/2004	US20040216179 Recombinant plasmid expressing two fluorescence genes
10/28/2004	US20040216178 Knockout expression vector which targets preferential ocogenic gene for use as tool in treatment of cell proliferative diseases
10/28/2004	US20040216177 Congenic rats containing a mutant GPR10 gene
10/28/2004	US20040216176 Compositions and methods for characterizing and regulating Wnt pathways
10/28/2004	US20040216174 Screening assays for targets and drugs useful in treatment and prevention of lipid metabolism disorders
10/28/2004	US20040215008 Production of proteins by autoproteolytic cleavage
10/28/2004	US20040215007 Comprises nucleotide sequences coding polypeptide for use in identifying modulators for treatment of cell proliferative, nervous system and inflammatory diseases
10/28/2004	US20040214998 siderophores; batch affinity chromatography; for detecting antibiotic resistance
10/28/2004	US20040214996 Multimeric peptides/immunoglobulins for use in the treatment of bone disorders
10/28/2004	US20040214995 Melanoma antigens and their use in diagnostic and therapeutic methods
10/28/2004	US20040214992 Mutation induced optimization of receptor signal to noise ratio
10/28/2004	US20040214990 Transmembrane protein differentially expressed in cancer
10/28/2004	US20040214988 Preparing leucine zipper and coiled-coil proteins in which leucine residues have been replaced with 5,5,5-trifluoroleucines; site-directed mutagenesis; mimetics; improved heat/chemical resistance
10/28/2004	US20040214881 Method for producing optically active halopropanediol derivative
10/28/2004	US20040214779 complexes, expression vectors and host cells transformed or transfected with nucleic acid molecules encoding MAGE-C2; for provoking a cytolytic T cell response; for determining if a cell presents a Human Leukocyte Antigen(HLA) molecule on its surface; diagnostic and therapeutic assays; tumor monitoring
10/28/2004	US20040214777 Peptide activators of VEGF
10/28/2004	US20040214776 (truncated GDNF) proteins that promote dopamine uptake by dopaminergic cells and promote the survival of nerve cells
10/28/2004	US20040214775 Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein
10/28/2004	US20040214773 Methods and compositions for the inhibition of cathepsins
10/28/2004	US20040214770 Hemoactive compositions and methods for their manufacture and use
10/28/2004	US20040214768 immunogenic polypeptides containing both self and non-self amino acid segments, used for prophylaxis of sepsis, cardiovascular disorders, adult respiratory distress syndrome, nephritis, graft rejection, arthritis, asthma, inflammatory bowel disease, multiple sclerosis and arteriosclerosis in mammals
10/28/2004	US20040214765 Methods and means for inhibition of CDK4 activity
10/28/2004	US20040214763 Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein
10/28/2004	US20040214760 Inhibition pf protein-phosphatases for the treatment of heart failure
10/28/2004	US20040214759 Compositions and methods of use for a fibroblast growth factor
10/28/2004	US20040214758 polynucleotides that code for polypeptides having asparaginase activity, used for prevention of cell proliferation and cell differentiation, metabolic, cardiovascular and liver disorders, viral diseases and as immunology modulators
10/28/2004	US20040214757 nuclear proteins which binds, in a sequence specific manner, to regulatory sequences of immunoglobulin light or heavy chain genes; bioassay
10/28/2004	US20040214748 Hemoglobin conjugates
10/28/2004	US20040214349 Molecular marker
10/28/2004	US20040214331 Transforming and propagating viral-like particle in cells; for use as tools in prevention and treatment of viral infection; viricides and genetic vaccines
10/28/2004	US20040214328 Multifunctional molecular complexes for gene transfer to cells
10/28/2004	US20040214321 Agent for inducing conversion of intestinal cells into insulin-producing cells and antidiabetic drug
10/28/2004	US20040214318 Viral expression vector comprising enhancing regulatory sequences for use as heterologous gene transfer and expression tool; in vitro transcription/translation systems
10/28/2004	US20040214317 Nucleotide sequences coding membrane protein for use in treatment and prevention of anxiolytic, brain and nervous system disorders
10/28/2004	US20040214304 Microbiocidal gastrointestinal microorganism for use in food processing and the prevention of infection; bacteriocin
10/28/2004	US20040214303 Complex
10/28/2004	US20040214287 Modified cytokines generated via site directed mutagenesis for use as long acting, user-friendly, therapeutic proteins; cachexia treatment and bioreactors
10/28/2004	US20040214286 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy
10/28/2004	US20040214285 HIV-specific fusion proteins and therapeutic and diagnostic methods for use
10/28/2004	US20040214284 Isolated peptides which bind to MHC class II molecules, and uses thereof
10/28/2004	US20040214283 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof
10/28/2004	US20040214282 Prokaryotic collagen-like proteins and uses thereof
10/28/2004	US20040214279 Insect monoamine transporter and methods of use thereof
10/28/2004	US20040214277 Methods and compositions for polypeptide engineering
10/28/2004	US20040214273 Method for secretory production of glycoprotein having human-type sugar chain using plant cell
10/28/2004	US20040214272 Nucleic acid molecules and other molecules associated with plants
10/28/2004	US20040214269 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/28/2004	US20040214268 Comprises nucleotide sequences coding membrane proteins for stimulating release of tumor necrosis factor and/or cell proliferation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/28/2004	US20040214267 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/28/2004	US20040214266 Secreted and transmembrane polypeptides nucleic acids encoding the same
10/28/2004	US20040214265 Comprises nucleotide sequences coding membrane proteins for stimulating release of tumor necrosis factor and/or cell proliferation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/28/2004	US20040214262 Bioactive peptides, uses thereof and process for the production of same
10/28/2004	US20040214255 Compositions and methods for treating diabetes
10/28/2004	US20040214251 Immunogenic label for detection of low concentrations of viral therapeutics/antibodies in blood; diagnosing/detecion/monitoring viral drug resistance; immunoassay
10/28/2004	US20040214250 Peptide-based fluorescence polarization assay for detection of antibodies to mycobacterium bovis
10/28/2004	US20040214247 Comprises immunoglobulin which binds to tumor specific epitope and inhibits binding of matrix protein/collagen/gelatin complexes; immunotherapy and antitumor agents
10/28/2004	US20040214239 Functional coupling of T1Rs and T2Rs by GI proteins, and cell-based assays for the identification of T1R and T2R modulators
10/28/2004	US20040214238 Nociceptive neuron specific calcium channel isoform and uses thereof
10/28/2004	US20040214233 Protein microarray system
10/28/2004	US20040214231 Methods of testing for allergic diseases,and therapeutic agents for treating same
10/28/2004	US20040214229 Amino acid sequences for use in diagnosis, prevention and treatment of sepsis and infections
10/28/2004	US20040214228 Selecting glycoproteins with enhanced activities for use as diagnostic tools in disease diagnosis; glycomics; proteomics

1 ... 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 ... 2916